Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

8726

1

Virpax Pharmaceuticals, Inc. Virpax Pharmaceuticals Reports Significant Financial Changes, Ongoing Losses, and Leadership Shifts in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

8727

1

ELUTIA INC. Elutia Inc. Reports Mixed Q3 Results, Net Income Turnaround Amid Ongoing Challenges

Via official filing (AI summary) | 6 months ago | 0 comments

8728

1

Lowell Farms Inc. Lowell Farms Reports Significant Financial Challenges in Q3 2024, Seeks to Stabilize Position

Via official filing (AI summary) | 6 months ago | 0 comments

8729

1

Research Solutions, Inc. Research Solutions Reports 19.7% Revenue Growth, Turnaround to Profitability in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8730

1

Knightscope, Inc. Knightscope Reports 23.9% Decline in Revenue for Q3 2024, Net Loss of $10.9 Million

Via official filing (AI summary) | 6 months ago | 0 comments

8731

1

Freeze Tag, Inc. Freeze Tag, Inc. Reports Decline in Revenue and Increased Net Losses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8732

1

Battery Future Acquisition Corp. Battery Future Acquisition Corp. Reports $2.2M Net Income for Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8733

1

Cineverse Corp. Cineverse Corp. Reports Decline in Revenue and Increased Net Losses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8734

1

FRANKLIN WIRELESS CORP Franklin Wireless Reports 38% Revenue Growth, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8735

1

CNS Pharmaceuticals, Inc. CNS Pharmaceuticals Reports Significant Financial Developments, Raises Capital, and Advances Pipeline in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8736

1

Bayview Acquisition Corp Bayview Acquisition Corp Reports Net Income of $583,558 in Latest Quarter, Pursues Business Combination with Oabay Holding Company

Via official filing (AI summary) | 6 months ago | 0 comments

8737

1

TRANS LUX Corp TRANS LUX Corp Reports Net Loss of $3.1 Million for Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8738

1

Actinium Pharmaceuticals, Inc. Actinium Pharmaceuticals Reports $11.6M Net Loss, Reduces Workforce by 20% in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8739

1

Fundamental Global Inc. Fundamental Global Reports 155.8% Revenue Growth, Net Loss in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

8740

1

Kinetic Seas Inc. Bellatora, Inc. (Now Kinetic Seas Incorporated) Reports First-Ever Consulting Revenue, Significant Operating Losses in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8741

1

Momentus Inc. Momentus Inc. Reports Improved Financial Performance, Reduced Losses, and Increased Capital Raising in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8742

1

BLUSKY AI INC. Inception Mining Reports Significant Financial Changes, Net Loss, and Shift in Focus to Consulting

Via official filing (AI summary) | 6 months ago | 0 comments

8743

1

READING INTERNATIONAL INC Reading International Reports Decline in Revenue and Profitability for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8744

1

Cosmos Health Inc. Cosmos Health Reports 7.1% Revenue Growth, Net Loss in Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8745

1

PRECIGEN, INC. Precigen Reports Significant Financial Challenges, Net Loss Increases 21.1% in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8746

1

Senti Biosciences, Inc. Senti Biosciences Reports Significant Financial Challenges, No Revenue in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

8747

1

HARTE HANKS INC Harte Hanks Reports Mixed Q3 2024 Results with Slight Revenue Growth and Operating Loss

Via official filing (AI summary) | 6 months ago | 0 comments

8748

1

CIRTRAN CORP CirTran Corporation Reports Significant Declines in Financial Performance for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

8749

1

Compass Digital Acquisition Corp. Compass Digital Acquisition Corp. Reports Significant Financial Changes, Suspends Trading on Nasdaq

Via official filing (AI summary) | 6 months ago | 0 comments

8750

1

Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals Reports Significant Financial Decline in 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments